Zobrazeno 1 - 10
of 23
pro vyhledávání: '"NAC, neoadjuvant chemotherapy"'
Autor:
Junichi Shindoh, Masayuki Urabe, Masaji Hashimoto, Ryosuke Umino, Yuta Kobayashi, Satoshi Okubo
Publikováno v:
International Journal of Surgery Case Reports
Highlights • We performed extended DP-CAR with resection of the confluence of GDA and PHA. • The presence of r-RHA could reduce the risk of ischemic complications. • Further, r-RHA could be a practical choice to expand surgical margin in DP-CAR
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 53, Iss, Pp 189-200 (2020)
Breast, Vol 53, Iss, Pp 189-200 (2020)
Background The axillary reverse mapping (ARM) technique, identify and preserve arm nodes during sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND), was developed to prevent breast-cancer related lymphedema (BCRL) remains contr
Publikováno v:
International Journal of Surgery Case Reports
Introduction: Perioperative chemotherapy could improve oncological outcomes for patients with advanced colon cancer. However, the effectiveness of triplet chemotherapy in the neoadjuvant setting is still unknown. Presentation of case: A 61-year-old m
Publikováno v:
Breast, Vol 49, Iss, Pp 115-122 (2020)
The Breast : official journal of the European Society of Mastology
The Breast : official journal of the European Society of Mastology
In patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy (NAC), some patients achieve a complete pathologic response (pCR), some achieve a partial response, and some do not respond at all or even progress. Accurate predicti
Autor:
Shin Takayama, Akihiko Suto, Nachiko Uchiyama, Takayuki Kinoshita, Kenjiro Jimbo, Takeshi Murata, Mari Kikuchi, Kaishi Satomi, Masayuki Yoshida, Akiko Miyagi Maeshima, Chikashi Watase, Sho Shiino, Momoko Tokura
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Breast cancer arising in association with a fibroadenoma (FA) is rare and usually early-stage. • We report a rare case of an advanced triple negative breast cancer, with lymph node metastases, within a long-standing FA. • Pathologi
Publikováno v:
International Journal of Surgery Case Reports
Highlights • DP-CAR: A rare, technically demanding operation with significant morbidity & mortality. • DP-CAR may provide curative (R0) resection of an otherwise unresectable cancer. • Our patient had optimal perioperative outcome and excellent
Autor:
Hong Li, Jun-Hua Nie, Tao Yang, Bo-Le Du, Guo-Qing Zhong, Jin Xiao, Yu Zhang, Ting-Ting Li, Zhi Li, Hai-Shan Ye, Chi Zhang, Jia Liu, Jian-Li He, Wen-Han Huang
Publikováno v:
Journal of Bone Oncology, Vol 30, Iss, Pp 100391-(2021)
Journal of Bone Oncology
Journal of Bone Oncology
Highlights • GPC3 mutation in primary osteosarcoma becomes abundant in its metastasis. • Mutant GPC3 is over-produced in metastatic spheroids with multidrug resistance. • Anti-GPC3 antibody effectively commits metastatic spheroids to apoptosis.
Autor:
Rizal Sanif Sanusi
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background: The latest World Health Organization (WHO) inquiry on the epidemiology of cervical cancers indicate there are approximately 528,000 new cases per year, ranking fourth after breast, colorectal and lung cancer. The validity of neoadjuvant c
Autor:
Jingying Jiang, Chi Chen, Fei Ji, Jie Tian, Xiaosheng Zhuang, Min-Yi Cheng, Teng Zhu, Liulu Zhang, Zhenyu Liu, Xuezhi Zhou, Junsheng Zhang, Kun Wang, Chuqian Lei
Publikováno v:
Translational Oncology, Vol 13, Iss 11, Pp 100831-(2020)
Translational Oncology
Translational Oncology
Objectives Breast cancers show different regression patterns after neoadjuvant chemotherapy. Certain regression patterns are associated with more reliable margins in breast-conserving surgery. Our study aims to establish a nomogram based on radiomic
Publikováno v:
International Journal of Surgery Case Reports
Highlights • There is no standard therapy for locally advanced TNBC showing disease progression during NAC. • We presented a case of locally advanced TNBC showing pCR to weekly paclitaxel with bevacizumab treatment showing PD during standard NAC.